tradingkey.logo
tradingkey.logo
Search

Neuropace Inc

NPCE
Add to Watchlist
16.140USD
+0.370+2.35%
Close 07/02, 13:00ETQuotes delayed by 15 min
541.90MMarket Cap
LossP/E TTM

More Details of Neuropace Inc Company

NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. The RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorders.

Neuropace Inc Info

Ticker SymbolNPCE
Company nameNeuropace Inc
IPO dateApr 22, 2021
CEOBecker (Joel D)
Number of employees184
Security typeOrdinary Share
Fiscal year-endApr 22
Address455 N. Bernardo Avenue
CityMOUNTAIN VIEW
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94043
Phone16502372700
Websitehttps://www.neuropace.com/
Ticker SymbolNPCE
IPO dateApr 22, 2021
CEOBecker (Joel D)

Company Executives of Neuropace Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
599.53K
+0.73%
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
366.48K
+89.08%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
110.42K
-0.30%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
68.67K
+24.49%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
23.04K
+16.84%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
18.54K
+19.85%
Ms. Renee Ryan
Ms. Renee Ryan
Independent Director
Independent Director
--
--
Ms. Lisa Andrade
Ms. Lisa Andrade
Independent Director
Independent Director
--
--
Mr. Joel D. Becker
Mr. Joel D. Becker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
599.53K
+0.73%
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
366.48K
+89.08%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
110.42K
-0.30%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
68.67K
+24.49%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
23.04K
+16.84%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
18.54K
+19.85%

FAQs

Who are the top five shareholders of Neuropace Inc?

The top five shareholders of Neuropace Inc are: Mr. Frank M. Fischer

How many institutions hold shares of Neuropace Inc (NPCE)?

As of 2026Q1, 223 institutions hold shares of Neuropace Inc, with a combined market value of approximately 33.54M, accounting for 99.26% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -4152379.00.